GB202105044D0 - Fusion protein - Google Patents

Fusion protein

Info

Publication number
GB202105044D0
GB202105044D0 GBGB2105044.8A GB202105044A GB202105044D0 GB 202105044 D0 GB202105044 D0 GB 202105044D0 GB 202105044 A GB202105044 A GB 202105044A GB 202105044 D0 GB202105044 D0 GB 202105044D0
Authority
GB
United Kingdom
Prior art keywords
fusion protein
fusion
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB2105044.8A
Other versions
GB2606693A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Exosis Inc
Original Assignee
Exosis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Exosis Inc filed Critical Exosis Inc
Priority to GB2105044.8A priority Critical patent/GB2606693A/en
Publication of GB202105044D0 publication Critical patent/GB202105044D0/en
Priority to PCT/US2022/023864 priority patent/WO2022216949A1/en
Publication of GB2606693A publication Critical patent/GB2606693A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/165—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/03—Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C07K2319/43—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a FLAG-tag
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
GB2105044.8A 2021-04-08 2021-04-08 Fusion protein Pending GB2606693A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB2105044.8A GB2606693A (en) 2021-04-08 2021-04-08 Fusion protein
PCT/US2022/023864 WO2022216949A1 (en) 2021-04-08 2022-04-07 Fusion protein for antigen presentation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2105044.8A GB2606693A (en) 2021-04-08 2021-04-08 Fusion protein

Publications (2)

Publication Number Publication Date
GB202105044D0 true GB202105044D0 (en) 2021-05-26
GB2606693A GB2606693A (en) 2022-11-23

Family

ID=75949647

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2105044.8A Pending GB2606693A (en) 2021-04-08 2021-04-08 Fusion protein

Country Status (2)

Country Link
GB (1) GB2606693A (en)
WO (1) WO2022216949A1 (en)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0918874T3 (en) 1996-08-16 2001-05-14 Medical Res Council Self-replicating episomal expression vectors that provide tissue-specific gene expression
WO2005120565A2 (en) * 2004-06-02 2005-12-22 New York Blood Center Sars vaccines and methods to produce highly potent antibodies
WO2017175253A1 (en) * 2016-04-04 2017-10-12 国立研究開発法人医薬基盤・健康・栄養研究所 Exosome-targeted dna vaccine
US20220184225A1 (en) * 2019-04-23 2022-06-16 Case Western Reserve University Fusogenic particles and related methods for delivering therapeutic agents to cells
AU2021220188A1 (en) * 2020-02-11 2022-09-08 Cytonus Therapeutics, Inc. Rapid vaccine platform
AU2021236385A1 (en) * 2020-03-13 2022-09-29 Capricor, Inc. Selectable marker proteins, expression vectors, for the production of virus-like particles for therapeutic and prophylactic applications
CN112226413B (en) * 2020-10-14 2022-04-15 苏州大学 Targeting exosome based on SARS-CoV-2S protein RBD region and preparation method thereof

Also Published As

Publication number Publication date
GB2606693A (en) 2022-11-23
WO2022216949A1 (en) 2022-10-13

Similar Documents

Publication Publication Date Title
EP3880814A4 (en) Fusion protein
SG11202011743SA (en) Fusion proteins comprising progranulin
EP3743438A4 (en) Cytokine fusion proteins
EP3757218A4 (en) Fusion protein
SG11202101904UA (en) Spd-1 variant - fc fusion proteins
IL290675A (en) Therapeutic fusion proteins
SG11202110400QA (en) Fusion protein and use thereof
ZA202003845B (en) Fusion proteins
IL273271A (en) Fusion protein comprising an fgf-18 moiety
SG11202000775SA (en) Fusion tags for recombinant protein expression
ZA202102533B (en) Fusion protein
GB2600564B (en) A fusion protein comprising IL13
EP3740501A4 (en) Fusion protein extensions
EP4100444A4 (en) Mucin-binding fusion proteins
EP4093875A4 (en) Ligand-binding fusion proteins
EP4107190A4 (en) Fusion proteins and uses thereof
GB202105044D0 (en) Fusion protein
GB202005879D0 (en) Heterodimeric proteins
GB202307936D0 (en) Fusion protein
GB202307932D0 (en) Fusion protein
EP3647426A4 (en) Fusion protein
EP3649159C0 (en) Fusion protein
GB202218084D0 (en) Fusion proteins
GB201712792D0 (en) Fusion protein
GB202113559D0 (en) Fusion polypeptide